nafagrel has been researched along with Acute Promyelocytic Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Homma, M; Ichikawa, Y; Kameda, H; Yoshida, T | 1 |
1 other study(ies) available for nafagrel and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Thromboxane A2 synthase inhibitor, DP-1904, decreases TNF alpha secretion from monocytes and inhibits E-selectin and ICAM-1 expression on the endothelial cell surfaces.
Topics: Cell Adhesion; Cell Adhesion Molecules; Cell Line; Cell Membrane; Cells, Cultured; E-Selectin; Endothelium, Vascular; Humans; Imidazoles; In Vitro Techniques; Intercellular Adhesion Molecule-1; Leukemia, Promyelocytic, Acute; Monocytes; Tetrahydronaphthalenes; Thromboxane-A Synthase; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Umbilical Veins | 1995 |